MEI Pharma, Inc. (MEIP) Social Stream
MEI PHARMA INC (MEIP) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering MEI PHARMA INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-07 | 5 | $17 | $7 | $10.4 | $5.91 | 75.97% |
| 2022-01-03 | 5 | $20 | $7 | $11 | $5.91 | 86.13% |
| 2022-02-14 | 6 | $20 | $4 | $9.833 | $5.91 | 66.38% |
| 2022-02-15 | 6 | $20 | $4 | $9.333 | $5.91 | 57.92% |
| 2022-03-25 | 7 | $15 | $1 | $5.142 | $5.91 | -12.99% |
| 2022-05-25 | 7 | $15 | $1 | $5.125 | $5.91 | -13.28% |
| 2022-06-07 | 6 | $15 | $0.5 | $5.062 | $5.91 | -14.35% |
| 2022-11-16 | 7 | $15 | $0.4 | $5.342 | $5.91 | -9.61% |
| 2022-12-05 | 8 | $8 | $0.4 | $4.057 | $5.91 | -31.35% |
| 2023-01-02 | 7 | $8 | $0.4 | $3.771 | $5.91 | -36.19% |
| 2023-02-10 | 7 | $8 | $0.1 | $3.728 | $5.91 | -36.92% |
| 2023-02-26 | 7 | $5 | $0.1 | $2.266 | $5.91 | -61.66% |
| 2023-05-11 | 4 | $80 | $2 | $30.666 | $5.91 | 418.88% |
| 2023-08-16 | 3 | $80 | $10 | $45 | $5.91 | 661.42% |
| 2023-09-27 | 3 | $42 | $9 | $25.5 | $5.91 | 331.47% |
| 2023-11-10 | 2 | $42 | $8 | $25 | $5.91 | 323.01% |
The Trend in the Analyst Price Target
Over the past 23 months, MEIP's average price target has gone up $14.6.
Over the past 39 weeks, MEIP's average upside potential has been 5,032.04%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-10 | 7 | 8 | 0.1 | 3.728 | 0.286 | 1203.5% |
| 2023-02-13 | 7 | 5 | 0.1 | 2.266 | 0.301 | 652.82% |
| 2023-02-26 | 4 | 5 | 0.1 | 2.400 | 0.210 | 1042.86% |
| 2023-02-26 | 4 | 80 | 2.0 | 30.666 | 0.210 | 14502.86% |
| 2023-08-16 | 3 | 80 | 10.0 | 45.000 | 6.870 | 555.02% |
MEIP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 17 months, MEIP's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- MEI PHARMA INC's variance in analysts' estimates is lower than -2240.76% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, MEI PHARMA INC's upside potential (average analyst target price relative to current price) is greater than 1002.78% of them.
- In terms of how MEI PHARMA INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 669.16% of that group.
- MEIP has a greater number of analysts covering the stock than 1490.05% of stocks in the small market cap category.
In the Pharmaceutical Products industry, ONCT, MTEM, and LUMO are the three stocks most similar to MEI PHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for MEIP? Use POWR Ratings for clearer insight into price direction.